Pricing

Ohio Husband And Wife File Xarelto Lawsuit

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

TheProductLawyers.com comments on another independent lawsuit filed against Xarelto and the drug's manufacturers—Bayer AG and Janssen Pharmaceuticals (a division of Johnson & Johnson.) Set in motion by a husband and wife from Ohio, the suit alleges that Xarelto directly caused the woman to suffer significant health issues, including a potentially fatal bleeding episode and anemia.

The couple is seeking over $150,000 in reparations to defray the cost of both existing medical expenses and the future care that her injuries will necessitate. Originally, she was prescribed the new-generation anticoagulant because she suffers from a cardiac disorder known as atrial fibrillation. This can often place individuals at a heightened risk for stroke.

However, according to documentation accompanying the claim, she began experiencing difficulties within two months of beginning the Xarelto regimen. A rupture in her intestinal blood vessels was continuing to bleed, due to the anti-clotting action of the drug. The suit claims that this contributed directly to anemia and other factors that have substantially impaired her ability to live a full life.

The FDA approved Xarelto for public use in 2011 as a new way to prevent blood clots.

Originally, its stated uses included treatment for those suffering from pulmonary embolism or deep vein thrombosis and patients recovering from hip or knee replacement surgeries. However, the approved uses soon expanded to include it as a preventative measure in the treatment of atrial fibrillation.

While it was initially heralded as a wonder drug, Xarelto has since accumulated more than 3,000 lawsuits against it, many with similar claims. The plaintiffs claim that they were placed at undue risk to suffer catastrophic bleeding events, some of which proved fatal, by taking the drug. In recent months, many of these suits were consolidated into a multidistrict litigation (MDL 2592), which will be tried in the Eastern District of Louisiana under Judge Eldon Fallon. This case and all subsequently filed lawsuits in the U.S. will be incorporated into the MDL.

The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-997-3792.

Download as PDF Single Release RSS Feed
Facebook Twitter Reddit LinkedIn Email

About TheProductLawyers.com :

TheProductLawyers.com is a resource website sponsored by Banville Law to provide information on pending lawsuits against defective products, drugs and medical devices.

Contact TheProductLawyers.com:

Banville Law

165 West End Ave #1h,
New York, NY 10023

888-478-9711

Additional News Releases From TheProductLawyers.com:

November 30, 2016Research Indicates New Form Of Treating Ovarian Cancer As Talcum Powder Lawsuit Numbers Climb

November 30, 2016Parties in Talcum Powder Lawsuit In Missouri Exchange Briefings

November 30, 2016J&J Requests Disclosure Of Third Party Litigation Financing In Talcum Powder Lawsuit

November 30, 2016Delaware Sees 10 New Talcum Powder Lawsuit Filings

November 29, 2016Philadelphia Talcum Powder Lawsuit Filed Against Johnson & Johnson To Proceed

November 29, 2016Pennsboro Woman Files Talcum Powder Lawsuit On Behalf Of Her Deceased Mother

November 29, 2016Bioimaging Helps Early Detection Of Ovarian Cancer As Talcum Powder Lawsuit Filings Continue

November 28, 2016FDA Follow-Up: How Officials Have Responded To The Influx Of Talcum Powder Lawsuit Filings

November 28, 2016Talc Uses: A Look At The Product At The Center Of Talcum Powder Lawsuit Filings

November 28, 2016More Women Encouraged To File A Talcum Powder Lawsuit After Verdicts